Bone Biologics
A publicly-held Biotechnology Company.
Launch date
Employees
Market cap
€1.3m
Enterprise valuation
(€810k) (Public information from Sep 2024)
Share price
$1.82 BBLG
Edison New Jersey (HQ)
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
EBITDA | (<1m) | (1.1m) | (4.4m) | (9.9m) | - | - | - |
Profit | (1.8m) | (1.6m) | (1.5m) | (8.9m) | (8.3m) | (4.4m) | (4.6m) |
EV / EBITDA | -278.9x | -33.1x | -0.7x | -0.2x | - | - | - |
R&D budget | <1m | <1m | 1.6m | 6.9m | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
$2.0m | Seed | ||
N/A | $5.8m | Post IPO Equity | |
N/A | N/A | IPO | |
$1.4m | Post IPO Equity | ||
$500k | Post IPO Equity | ||
N/A | $2.0m | Post IPO Debt | |
* | N/A | $5.1m | Post IPO Equity |
* | N/A | $5.0m | Post IPO Equity |
* | N/A | $729k | Private Placement VC |
* | N/A | $2.1m | Post IPO Equity |
Total Funding | €2.5m |
Related Content
Recent News about Bone Biologics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.